"synthetic derivatives of thc may weaken hiv-1 infection to enhance anti-viral therapies".... by activating the CB2 receptor.
sciencedaily.com/releases/2013/04/130430131530.htm
the interesting part is that they used jwh-133. one of "two commercially available cb2 agonists."
jleukbio.org/content/93/5/801
some people may recognize the jwh-xxx as being part of the "k2" or "spice" formulas, or
synthetic "cannabinoids".
because you cant patent thc or cbd.
sciencedaily.com/releases/2013/04/130430131530.htm
the interesting part is that they used jwh-133. one of "two commercially available cb2 agonists."
jleukbio.org/content/93/5/801
some people may recognize the jwh-xxx as being part of the "k2" or "spice" formulas, or
synthetic "cannabinoids".
because you cant patent thc or cbd.